Literature DB >> 21303406

Prebiotic treatment in experimental colitis reduces the risk of colitic cancer.

Yutaka Komiyama1, Keiichi Mitsuyama, Jyunya Masuda, Hiroshi Yamasaki, Hidetoshi Takedatsu, Akira Andoh, Osamu Tsuruta, Masanobu Fukuda, Osamu Kanauchi.   

Abstract

BACKGROUND AND AIM: Germinated barley foodstuff (GBF) is a prebiotic product that reduces colonic mucosal inflammation and the clinical symptoms observed in ulcerative colitis (UC). The risk of contracting colorectal cancer is higher in patients with UC than in that of the general population. The aim of this study is to apply this prebiotic approach to control chronic colitis and to reduce the incidence of colitic cancer.
METHODS: Repeated and intermitted dextran sulfate sodium administration to male Sprague-Dawley rats was used for the chronic and subacute colitis models. GBF was added as the diet (10% w/v). The incidence of adenomatous high-grade dysplasia, and pathophysiological observations, including the proliferative cell nuclear antigen (PCNA) labeling index, and clinical score, cecal organic acid profile, and the accompanying β-glucosidase activity were determined.
RESULTS: In the chronic phase, the incidence of adenomatous dysplasia was only confirmed in the control group, and the GBF group had no dysplasia in the entire colon; the stratified squamous epithelium area of GBF was significantly lower than that of the controls. GBF treatment significantly lowered the cecal succinate content and significantly increased β-glucosidase activity compared to the controls. In addition, colonic mucosal inflammatory damage was comparable between the two groups, while the PCNA labeling index of the colonic mucosa in the GBF group was significantly lower than that of the control group. However, in the subacute phase, the mucosal damage score of GBF was significantly attenuated, and the PCNA labeling index of the colonic mucosa in the GBF group was significantly higher than that of the control group.
CONCLUSION: This preliminary study demonstrated that GBF effectively prevents colitis-related dysplasia and inflammatory change in chronic and subacute colitis models by modulating the intestinal environment as a prebiotic. This prebiotic might contribute to the prevention of mucosal damage, to show different proliferative effects on the epithelium in the regeneration and steady states.
© 2011 Journal of Gastroenterology and Hepatology Foundation and Blackwell Publishing Asia Pty Ltd.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21303406     DOI: 10.1111/j.1440-1746.2011.06690.x

Source DB:  PubMed          Journal:  J Gastroenterol Hepatol        ISSN: 0815-9319            Impact factor:   4.029


  4 in total

1.  Preventive rather than therapeutic treatment with high fiber diet attenuates clinical and inflammatory markers of acute and chronic DSS-induced colitis in mice.

Authors:  Ana Letícia Malheiros Silveira; Adaliene Versiani Matos Ferreira; Marina Chaves de Oliveira; Milene Alvarenga Rachid; Larissa Fonseca da Cunha Sousa; Flaviano Dos Santos Martins; Ana Cristina Gomes-Santos; Angelica Thomaz Vieira; Mauro Martins Teixeira
Journal:  Eur J Nutr       Date:  2015-10-12       Impact factor: 5.614

Review 2.  Role of Short Chain Fatty Acids and Apolipoproteins in the Regulation of Eosinophilia-Associated Diseases.

Authors:  Eva Maria Sturm; Eva Knuplez; Gunther Marsche
Journal:  Int J Mol Sci       Date:  2021-04-22       Impact factor: 5.923

3.  Chemopreventive Effect of the Germinated Oat and its Phenolic-AVA Extract in Azoxymethane/Dextran Sulfate Sodium (AOM/DSS) Model of Colon Carcinogenesis in Mice.

Authors:  Margarita Damazo-Lima; Guadalupe Rosas-Pérez; Rosalía Reynoso-Camacho; Iza F Pérez-Ramírez; Nuria E Rocha-Guzmán; Ericka A de Los Ríos; Minerva Ramos-Gomez
Journal:  Foods       Date:  2020-02-10

4.  Application of genetic algorithm for discovery of core effective formulae in TCM clinical data.

Authors:  Ming Yang; Josiah Poon; Shaomo Wang; Lijing Jiao; Simon Poon; Lizhi Cui; Peiqi Chen; Daniel Man-Yuen Sze; Ling Xu
Journal:  Comput Math Methods Med       Date:  2013-10-30       Impact factor: 2.238

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.